Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform.
Costello RE, Waller KMJ, Smith R, Mells GF, Wong AYS, Schultze A, Mahalingasivam V, Herrett E, Zheng B, Lin LY, MacKenna B, Mehrkar A, Bacon SCJ, Goldacre B, Tomlinson LA, Tazare J, Rentsch CT; OpenSAFELY collaborative; LH&W NCS (or CONVALESCENCE) Collaborative.
Costello RE, et al. Among authors: lin ly.
Commun Med (Lond). 2024 Nov 19;4(1):238. doi: 10.1038/s43856-024-00664-y.
Commun Med (Lond). 2024.
PMID: 39562612
Free PMC article.